These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12225395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E, Szmigielska A, Robak T.
    Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
    [Abstract] [Full Text] [Related]

  • 3. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T, Szmigielska A.
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A, Smolewski P, Najder M, Robak T.
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [Abstract] [Full Text] [Related]

  • 5. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1993 Sep; 24(2):177-82. PubMed ID: 8103959
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S, Ogawa M.
    Cancer Chemother Pharmacol; 1982 Sep; 8(2):157-62. PubMed ID: 7105379
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of new morpholino anthracyclines.
    Komeshima N, Tsuruo T, Umezawa H.
    J Antibiot (Tokyo); 1988 Apr; 41(4):548-53. PubMed ID: 3163685
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 Apr; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 9. The influence of 2-chlorodeoxyadenosine (2-CdA) alone and in combination with cyclophosphamide or methotrexate on normal and leukemic hematopoiesis.
    Góra-Tybor J, Robak T.
    Adv Exp Med Biol; 1994 Apr; 370():129-30. PubMed ID: 7660874
    [No Abstract] [Full Text] [Related]

  • 10. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS, Chitnis MP.
    Oncology; 1990 Apr; 47(2):166-9. PubMed ID: 2314829
    [Abstract] [Full Text] [Related]

  • 11. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
    Dai ZQ, Xu JY, Yuan XJ, Cai JC.
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):69-71. PubMed ID: 8737460
    [Abstract] [Full Text] [Related]

  • 12. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
    Ganapathi R, Grabowski D, Sweatman TW, Seshadri R, Israel M.
    Br J Cancer; 1989 Dec; 60(6):819-26. PubMed ID: 2605093
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxic effect of cyclosporin A alone and in combination with 2-chlorodeoxyadenosine against P388 murine leukemia in vivo.
    Józefowicz-Okonkwo G, Szmigielska-Kapłon A, Robak T.
    Med Sci Monit; 2002 Sep; 8(9):BR373-7. PubMed ID: 12218939
    [Abstract] [Full Text] [Related]

  • 14. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA, Wodinsky I.
    Cancer; 1983 Feb 15; 51(4):600-5. PubMed ID: 6401590
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N, Blake C, Broadhurst MJ, Bushnell DJ, Hassall CH, Hartmann HR, Keech E, Stratton AR, Thomas GJ.
    J Med Chem; 1990 Sep 15; 33(9):2375-9. PubMed ID: 2391681
    [Abstract] [Full Text] [Related]

  • 16. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A, Kuriyama H, Kiyota T.
    Gan To Kagaku Ryoho; 1996 Feb 15; 23(3):291-6. PubMed ID: 8712821
    [Abstract] [Full Text] [Related]

  • 17. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Feb 15; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 18. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M, Hoshi A.
    Eur J Cancer Clin Oncol; 1984 Mar 15; 20(3):411-5. PubMed ID: 6323189
    [Abstract] [Full Text] [Related]

  • 19. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.
    Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, Mumper RJ.
    J Biomed Nanotechnol; 2009 Apr 15; 5(2):151-61. PubMed ID: 20055093
    [Abstract] [Full Text] [Related]

  • 20. Antileukemic activity of 4-demethoxydaunorubicin in mice.
    Casazza AM, Pratesi G, Giuliani F, Di Marco A.
    Tumori; 1980 Oct 31; 66(5):549-64. PubMed ID: 6936969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.